Jounce Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Jounce Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 205% to $82,000,000. The net income raised on -$50,919,000 and profit margin reached -62%. Total operating expenses were $134,242,000.

Profit Margin

Jounce Therapeutics, Inc. (NASDAQ:JNCE): Profit margin
2014 0 -10.51M
2015 0 -28.53M
2016 37.19M -13.70M -36.84%
2017 71.64M -16.44M -22.95%
2018 65.20M -27.37M -41.99%
2019 147.87M 56.82M 38.43%
2020 62.33M -43.84M -70.33%
2021 26.90M -90.87M -337.73%
2022 82M -50.91M -62.1%

JNCE Income Statement (2014 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
82M26.90M62.33M147.87M65.20M71.64M37.19M00
Cost of revenue
000000000
Gross profit
82M26.90M62.33M147.87M65.20M71.64M37.19M00
Operating exp.
Research and development
103.27M88.97M78.69M67.13M70.05M67.79M34.90M22.13M11.24M
Selling and marketing
000000000
Total operating expenses
134.24M117.96M107.45M95.05M96.49M90.85M51.66M30.39M16.21M
Operating income
-52.24M-91.05M-45.11M52.81M-31.29M-19.21M-14.46M-30.39M-16.21M
Other income (expenses), net
1.45M199K1.28M4.05M3.96M2.80M763K1.86M5.69M
Income before tax
-50.78M-90.85M-43.82M56.86M-27.33M-16.40M-13.70M-28.53M-10.51M
Income tax expense
135K15K14K46K46K36K763K1.86M5.69M
Net income
-50.91M-90.87M-43.84M56.82M-27.37M-16.44M-13.70M-28.53M-10.51M
Earnings per share
Basic EPS
-0.99-1.82-1.241.72-0.84-0.55-0.45-1.54-0.48
Diluted EPS
-0.99-1.82-1.241.66-0.84-0.55-0.45-1.54-0.48
Data sourceData sourceData sourceData sourceData sourceData sourceData source